Hemophilia - 100 Studies Found
| Completed |
: Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 : Hemophilia A : 2005-09-08 : Drug: Antihemophilic factor, recombinant, manufactured protein-free |
| Completed |
: Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients : Hemophilia A : 2005-09-09 : Biological: Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM) |
| Completed |
: Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A : Severe Haemophilia A : 2016-02-18 : Drug: Pharmacokinetic based dosage change Pharmacokinetic based dosing of factor VIII prophylaxis treatm |
| Completed |
: Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients : Hemophilia A : 2005-09-08 : Drug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment) |
| Completed |
: Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A : Hemophilia A : 2005-09-08 : Drug: Antihemophilic factor, recombinant, manufactured protein-free |
| Completed |
: Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 : Hemophilia A : 2005-09-08 : Drug: Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM) |
| Active, not recruiting |
: PK Driven Prophylaxis for Hemophilia A : Hemophilia A : 2015-12-08 : Device: MyPKFiT Adjustment of the treatment dose using a decision support software according to the PK v |
| Terminated |
: Individually Tailored Prophylaxis in Patients With Severe Hemophilia A : Hemophilia A : 2009-10-12 :
|
| Completed |
: Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients : Hemophilia A : 2016-03-30 :
|
| Completed |
: Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B : Hemophilia B : 2007-12-21 : Drug: Recombinant Factor IX Coagulation Benefix IV each 12 hours for 2 a 5 days |